Portland, OR, United States of America

Ashwani Kumar Narayana

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Modernatx, Inc., Oregon State University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashwani Kumar Narayana. Retrieved from https://idiyas.com/inventor/ashwani-kumar-narayana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ashwani Kumar Narayana: Innovator in Lipid Nanoparticle Formulation

Introduction

Ashwani Kumar Narayana is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of lipid nanoparticle formulations, which are crucial for the delivery of therapeutic agents.

Latest Patents

Narayana holds a patent for a lipid nanoparticle formulation. This patent features novel lipids and compositions that include an ionizable lipid, a phospholipid, and a sterol or tocopherol. The nanoparticle compositions are designed to deliver therapeutic and prophylactic agents, such as RNA, to mammalian cells or organs. This innovation aims to regulate polypeptide, protein, or gene expression effectively.

Career Highlights

Throughout his career, Ashwani Kumar Narayana has worked with prominent organizations, including Modernatx, Inc. and Oregon State University. His work has focused on advancing the field of nanoparticle technology and its applications in medicine.

Collaborations

Some of his notable coworkers include Siddharth Patel and Emily Robinson. Their collaborative efforts have contributed to the development of innovative solutions in the field of lipid formulations.

Conclusion

Ashwani Kumar Narayana's work in lipid nanoparticle formulation represents a significant advancement in therapeutic delivery systems. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…